Mona Alibolandi

7.3k total citations
165 papers, 5.9k citations indexed

About

Mona Alibolandi is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Mona Alibolandi has authored 165 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 71 papers in Biomaterials and 65 papers in Biomedical Engineering. Recurrent topics in Mona Alibolandi's work include Advanced biosensing and bioanalysis techniques (77 papers), Nanoparticle-Based Drug Delivery (63 papers) and RNA Interference and Gene Delivery (59 papers). Mona Alibolandi is often cited by papers focused on Advanced biosensing and bioanalysis techniques (77 papers), Nanoparticle-Based Drug Delivery (63 papers) and RNA Interference and Gene Delivery (59 papers). Mona Alibolandi collaborates with scholars based in Iran, United States and Canada. Mona Alibolandi's co-authors include Khalil Abnous, Mohammad Ramezani, Seyed Mohammad Taghdisi, Farzin Hadizadeh, Marzieh Mohammadi, Fatemeh Sadeghi, Noor Mohammad Danesh, Elnaz Bagheri, Sara Amel Farzad and Sahar Taghavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Mona Alibolandi

161 papers receiving 5.9k citations

Peers

Mona Alibolandi
Marissa E. Wechsler United States
Rebecca M. Haley United States
Min Suk Shim South Korea
Ji Hoon Jeong South Korea
Yuanpei Li United States
Mona Alibolandi
Citations per year, relative to Mona Alibolandi Mona Alibolandi (= 1×) peers Hu‐Lin Jiang

Countries citing papers authored by Mona Alibolandi

Since Specialization
Citations

This map shows the geographic impact of Mona Alibolandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Alibolandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Alibolandi more than expected).

Fields of papers citing papers by Mona Alibolandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Alibolandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Alibolandi. The network helps show where Mona Alibolandi may publish in the future.

Co-authorship network of co-authors of Mona Alibolandi

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Alibolandi. A scholar is included among the top collaborators of Mona Alibolandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Alibolandi. Mona Alibolandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagheri, Elnaz, Mohammad Ramezani, Khalil Abnous, et al.. (2025). Targeted theranostic oxygen-filled and doxorubicin-loaded mesenchymal stem cell-derived exosomes-based-nanobubble against melanoma. Journal of Drug Delivery Science and Technology. 105. 106636–106636.
3.
Alibolandi, Mona, et al.. (2025). Preparation and characterization of metformin-loaded transdermal formulations based on liquid crystalline lipid particles in diabetic-induced rats. Journal of Drug Delivery Science and Technology. 105. 106634–106634. 1 indexed citations
4.
Toossi, Mohammad Taghi Bahreyni, et al.. (2024). Smart bismuth-based platform: A focus on radiotherapy and multimodal systems. Journal of Drug Delivery Science and Technology. 101. 106136–106136. 2 indexed citations
5.
Abnous, Khalil, Seyed Mohammad Taghdisi, Ameneh Sazgarnia, et al.. (2024). Multifunctional polypeptide-based polymersome for chemophotothermal therapy of melanoma in vitro and in vivo. Journal of Drug Delivery Science and Technology. 94. 105526–105526. 10 indexed citations
6.
Zahiri, Mahsa, Hossein Kamali, Khalil Abnous, et al.. (2024). Synthesis of folate targeted theranostic cubosomal platform for co-delivery of bismuth oxide and doxorubicin to melanoma in vitro and in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 198. 114259–114259. 11 indexed citations
7.
Taghavi, Sahar, Sirous Nekooei, Khalil Abnous, et al.. (2024). Synthesis of targeted doxorubicin-loaded gold nanorod −mesoporous manganese dioxide core–shell nanostructure for ferroptosis, chemo-photothermal therapy in vitro and in vivo. International Journal of Pharmaceutics. 665. 124725–124725. 11 indexed citations
8.
Aliabadi, Ali, et al.. (2024). Nucleolin-targeted cationic nanoparticle for delivery of survivin shRNA against colorectal cancer in vitro and in vivo. European Polymer Journal. 208. 112872–112872. 5 indexed citations
9.
Alibolandi, Mona, et al.. (2024). A four in one nanoplatform: Theranostic bismuth-containing nanoMOFs for chemo-photodynamic- radiation therapy and CT scan imaging. International Journal of Pharmaceutics. 668. 124971–124971. 1 indexed citations
10.
Dehghani, Sadegh, Morteza Alinezhad Nameghi, Mohammad Ramezani, et al.. (2024). Engineering extracellular vesicles derived from lemons for delivering chemotherapeutic drug employing periostin targeting. Journal of Drug Delivery Science and Technology. 99. 106011–106011. 4 indexed citations
11.
Ramezani, Mohammad, et al.. (2023). Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures. International Journal of Pharmaceutics. 646. 123448–123448. 16 indexed citations
12.
Aliabadi, Ali, Khalil Abnous, Seyed Mohammad Taghdisi, et al.. (2023). Amphiphilic polylactic acid-b-poly(N-(3-aminopropyl) methacrylamide) copolymers: Self-assembly to polymeric micelles for gene delivery. Journal of Drug Delivery Science and Technology. 91. 105236–105236. 4 indexed citations
13.
Abnous, Khalil, et al.. (2023). Oral non-viral gene delivery platforms for therapeutic applications. International Journal of Pharmaceutics. 642. 123198–123198. 3 indexed citations
14.
Mohammadi, Marzieh, Mona Alibolandi, Khalil Abnous, et al.. (2020). Comparison of liposomal formulations incorporating BMP-2 peptide to induce bone tissue engineering. SHILAP Revista de lepidopterología. 5 indexed citations
15.
Bagheri, Elnaz, Legha Ansari, Khalil Abnous, et al.. (2020). Silica -magnetic inorganic hybrid nanomaterials as versatile sensing platform. SHILAP Revista de lepidopterología. 5 indexed citations
16.
Zahiri, Mahsa, Maryam Babaei, Khalil Abnous, et al.. (2019). Hybrid nanoreservoirs based on dextran‐capped dendritic mesoporous silica nanoparticles for CD133‐targeted drug delivery. Journal of Cellular Physiology. 235(2). 1036–1050. 46 indexed citations
17.
Mansouri, Atena, Khalil Abnous, Mona Alibolandi, Seyed Mohammad Taghdisi, & Mohammad Ramezani. (2019). Targeted delivery of tacrolimus to T cells by pH‐responsive aptamer‐chitosan‐ poly(lactic‐co‐glycolic acid) nanocomplex. Journal of Cellular Physiology. 234(10). 18262–18271. 18 indexed citations
18.
Alibolandi, Mona, et al.. (2016). Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles. SHILAP Revista de lepidopterología. 10 indexed citations
19.
Alibolandi, Mona, et al.. (2016). Evaluation of the effect of crocetin on antitumor activity of doxorubicin encapsulated in PLGA nanoparticles. 3(1). 23–34. 19 indexed citations
20.
Alibolandi, Mona, et al.. (2010). High level expression of human basic fibroblast growth factor in Escherichia coli: Evaluating the effect of the GC content and rare codons within the first 13 codons. AFRICAN JOURNAL OF BIOTECHNOLOGY. 9(16). 2456–2462. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026